Studies indicating a central antisecretory site of action for desmethylimipramine (DMI).
D000818:Animals; D002217:Carbachol / Q000494:pharmacology; D002746:Chlorpromazine / Q000494:pharmacology; D003891:Desipramine / Q000494:pharmacology*; D004285:Dogs; D004558:Electric Stimulation; D005260:Female; D005402:Fistula; D005745:Gastric Acidity Determination; D005750:Gastric Juice / Q000032:analysis / Q000378:metabolism*; D006584:Hexamethonium Compounds / Q000494:pharmacology; D006601:Hexoses / Q000494:pharmacology; D008297:Male; D011413:Propantheline / Q000494:pharmacology; D051381:Rats; D013270:Stomach / Q000187:drug effects / Q000502:physiology / Q000601:surgery; D014630:Vagus Nerve / Q000502:physiology
D006584:Hexamethonium Compounds; D006601:Hexoses; D011413:Propantheline; D002217:Carbachol; D003891:Desipramine; D002746:Chlorpromazine